Exogenous Gene Control via Modulation of RNA Self-Cleavage

通过调节 RNA 自切割来控制外源基因

• 批准号: 7082920
• 负责人: RICHARD C MULLIGAN
• 金额: $ 41.84万
• 依托单位: HARVARD MEDICAL SCHOOL
• 依托单位国家: 美国
• 财政年份: 2005
• 资助国家: 美国
• 起止时间: 2005-07-01 至 2009-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7082920
• 关键词: Lentivirus; RNA; Retroviridae; biotechnology; chemical cleavage; gene delivery system; gene expression; genetic regulation; genetic techniques; genetically modified animals; laboratory mouse; molecular genetics; oligonucleotides; ribozymes; small molecule; technology /technique development; transfection; transfection /expression vector

DESCRIPTION (provided by applicant): The ability to 'exogenously' control the expression of genes in mammalian cells has been a powerful tool of biomedical research. In particular, gene regulation technology has played a major role in efforts to understand the role of specific gene products in fundamental biological processes and in development and disease states. The technology also offers the opportunity to have a major impact in a number of other areas of research and could even form an important basis for new therapeutic paradigms. However, due to limitations of existing systems, there is a need for the development of new methods for achieving gene regulation in order to realize the full potential of the technology. The focus of this grant proposal is the development of a new technology platform for gene regulation which involves the modulation of RNA self-cleavage, rather than transcription, as a means of controlling gene expression. The basis for the proposed research program are recent studies in our laboratory which demonstrate that incorporation of sequences encoding self-cleaving RNA motifs, ribozymes (rz), into a mammalian transcription unit can lead to the elimination of gene expression from the resulting transcript, due to efficient self-cleavage of the mRNA. In turn, we have shown that gene expression from such a configuration can be effectively 'induced' via inhibition of RNA self-cleavage using small molecule inhibitors. We believe that such a system for gene regulation may offer distinct advantages over existing systems for controlling gene expression and could have broad experimental and therapeutic application. The overall objective of the research program described here is to further understand the experimental parameters which govern efficient RNA self-cleavage in mammalian cells, and to apply that knowledge, in conjunction with development of new methodologies for the manipulation of rz self-cleavage and standard gene transfer technology, to the development of a widely applicable and 'user-friendly' technology platform for gene regulation. An important goal of the research program will be to establish a general methodology for the development of 'custom-designed' rz-based gene regulation systems tailored to respond to any specific small molecule or other molecular entity.

描述（由申请人提供）：“外源性”控制哺乳动物细胞中基因表达的能力一直是生物医学研究的有力工具。特别是，基因调控技术在理解特定基因产物在基本生物过程以及发育和疾病状态中的作用方面发挥了重要作用。该技术还提供了在许多其他研究领域产生重大影响的机会，甚至可以为新的治疗模式奠定重要基础。然而，由于现有系统的限制，需要开发用于实现基因调控的新方法，以实现该技术的全部潜力。这项资助提案的重点是开发一种新的基因调控技术平台，该平台涉及调节RNA自切割，而不是转录，作为控制基因表达的一种手段。提出的研究计划的基础是我们实验室最近的研究，这些研究表明，将编码自切割RNA基序（核酶（rz））的序列掺入哺乳动物转录单位中，由于mRNA的有效自切割，可以导致从所得转录物中消除基因表达。反过来，我们已经表明，通过使用小分子抑制剂抑制RNA自切割，可以有效地“诱导”来自这种构型的基因表达。我们相信，这样一个系统的基因调控可能会提供明显的优势，现有的系统控制基因表达，并可能有广泛的实验和治疗应用。这里描述的研究计划的总体目标是进一步了解在哺乳动物细胞中管理有效的RNA自切割的实验参数，并将这些知识应用于开发用于操作RZ自切割和标准基因转移技术的新方法，以开发广泛适用的和“用户友好”的基因调控技术平台。该研究项目的一个重要目标是建立一种通用方法，用于开发“定制设计”的rz基因调控系统，以适应任何特定的小分子或其他分子实体。